Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of Immunodeficiency

medRxiv(2023)10.1101/2023.07.31.23293441Source: DataRank Database

SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of Immunodeficiency is a research paper published in medRxiv (2023). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: greenTopics (16)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (33)

Manish C. Choudhary ORCID,James Regan ORCID,Julie Boucau ORCID,Anusha Nathan ORCID,Tessa Speidel ORCID

Live enrichment

PubMed:37577493 OpenAlex:https://openalex.org/W4385497490

National Institutes of Health

Grant: 5P30AI036219-20

Ugandan Laboratory Core

National Institutes of Health

Grant: 5R01AR080659-02

Immunologic and Clinical Sequelae after COVID-19 in Patients with Systemic Autoimmune Rheumatic Diseases

National Institutes of Health

Grant: 2U19AI110818-06

Advancing Genomic Technologies to Combat Infectious Disease: Mapping Dynamics within Single Cells, Individual Hosts, and Global Populations

National Institutes of Health

Grant: 1R01AI176533-01

Investigating the Protective Efficacy of SIV/HIV T and B cell Immunity Induced by RNA Replicons

National Institutes of Health

Grant: 1P30AI060354-01

Harvard Medical School Center for AIDS Research

National Institutes of Health

Grant: 5DP2AI154421-04

Exploiting Highly Networked CTL Epitopes to Achieve a Functional HIV Cure

National Institutes of Health

Grant: 1DP1DA058476-01

Harnessing Highly Networked HLA-E-Restricted CTL Epitopes to Achieve a Broadly Effective HIV Cure

greenLicense: cc-by-nc-nd

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2023/08/07/2023.07.31.23293441.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.07.31.23293441

repositoryhttps://doi.org/10.1101/2023.07.31.23293441

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37577493

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studiesCOVID-19 Clinical Research Studies0303 health sciences03 medical and health sciences

Keywords

VirologyHuman immunodeficiency virus (HIV)Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunodeficiencyBiologyMedicineImmunologyInfectious disease (medical specialty)Internal medicineArticle

Sustainable Development Goals

SDG 0: Good health and well-being